Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Gastrointestinal 1Breast 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

venetoclax 190Cyclophosphamide 124Azacitidine 112Cytarabine 108fludarabine 92Specimen Handling 75Biopsy 54Daunorubicin 42Methotrexate 40Dexamethasone 37Rituximab 34blinatumomab 32Vincristine 31Decitabine 31fludarabine phosphate 30Injections 28Granulocyte Colony-Stimulating Factor 28Magnetic Resonance Spectroscopy 27Whole-Body Irradiation 26obinutuzumab 25Idarubicin 25acalabrutinib 23Mycophenolic Acid 23Prednisone 22Melphalan 21Busulfan 21gilteritinib 19Stem Cell Transplantation 19Doxorubicin 19ibrutinib 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anti-Bacterial Agents × Other hematologic neoplasm × Clear all
NCT05909293 2023-06-18

Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission

The First Affiliated Hospital with Nanjing Medical University

Phase NA Recruiting
100 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡